1. Home
  2. ARVN vs TLRY Comparison

ARVN vs TLRY Comparison

Compare ARVN & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$8.27

Market Cap

600.2M

Sector

Health Care

ML Signal

HOLD

Logo Tilray Brands Inc.

TLRY

Tilray Brands Inc.

HOLD

Current Price

$3.94

Market Cap

560.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARVN
TLRY
Founded
2015
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
600.2M
560.3M
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
ARVN
TLRY
Price
$8.27
$3.94
Analyst Decision
Buy
Strong Buy
Analyst Count
19
4
Target Price
$15.05
$72.33
AVG Volume (30 Days)
711.6K
3.3M
Earning Date
05-04-2026
04-01-2026
Dividend Yield
N/A
N/A
EPS Growth
58.84
55.69
EPS
1.70
N/A
Revenue
$262,600,000.00
N/A
Revenue This Year
N/A
$8.79
Revenue Next Year
N/A
$19.98
P/E Ratio
$4.89
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.97
$0.77
52 Week High
$14.22
$15.70

Technical Indicators

Market Signals
Indicator
ARVN
TLRY
Relative Strength Index (RSI) 38.71 33.64
Support Level $7.90 $3.67
Resistance Level $8.40 $4.91
Average True Range (ATR) 0.32 0.17
MACD -0.13 -0.06
Stochastic Oscillator 11.88 8.02

Price Performance

Historical Comparison
ARVN
TLRY

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

About TLRY Tilray Brands Inc.

Tilray is as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. The company portfolio includes brand such as Sweet Water Brewing, Montauk Brewing, Brew Dog, Shock Top, 10 Barrell, Breckenridge Brewery, Blue Point Brewing, Breckenridge Distillery, Revolver, Terrapin, Broken Coast, Good Supply, Redecan, Solei, Tilray, ARX, XMG, Manitoba Harvest and Hi-Ball. The company has four segment Beverage, Cannabis, Distribution and Wellness. The majority of the revenue is generated from Distribution business which encompasses the purchase and resale of pharmaceuticals products to customers.

Share on Social Networks: